PurpleLab™ CLEAR provides in-house data usability, making it easy for your team to get claims data insights in minutes, not hours or days.

Level up your audience segmentation Advertising is awash in data, but healthcare advertisers can struggle to separate valuable insights from noise when planning and optimizing campaigns. But how do you identify data that will actually help you build and optimize your campaigns? Watch this podcast to learn more about precise audience segmentation and gain valuable…

Osteoporosis and low bone mass affect almost 54 million people in the US, placing them at risk for hip, spine, wrist fractures, permanent pain, limited mobility, and increased morbidity and mortality. The disease affects people of all races, ethnicities, and gender, although significant variation within these groups does exist. For the over fifty population, osteoporosis…

Colorectal Cancer Awareness Month is observed in March to highlight the importance of screening for colorectal cancer, as well as to promote healthy lifestyle habits that can decrease a person’s risk of developing cancer of the colon, rectum or anus – the three distinct cancer types referred to as colorectal cancer (CRC). CRC Is the…

While there has always been a significant focus on how to effectively educate and market products to patients and healthcare providers (HCPs) there is another group that pharmaceutical manufacturers, specifically– Medical Affairs and Marketing teams need to reach, educate, and influence: . KOLs, often the most experienced in a therapy area, who also may be…

Over the last decade, the life sciences industry has used digital advertising at an increasing rate to engage with patients throughout the drug development life cycle. From creating disease state awareness, to driving drug adherence, the trend particularly accelerated during 2020 and 2021, as pharmaceutical brands looked for ways to stay engaged with their patients…

In 2019, the National Multiple Sclerosis Society published a series of findings with updated prevalence of the disease. Current estimates place the number of people diagnosed with Multiple Sclerosis (MS) at one million people in the US; double previously reported figures. It is a costly and chronic disease without an exact known cause or biomarker,…

February is low-vision month, and at PurpleLab we are focusing on Age-Related Macular Degeneration (AMD), one of the diseases responsible for this condition.  According to the Centers for Disease Control’s (CDC) Vision and Eye Health Surveillance System (VEHSS) about twenty million Americans aged forty and older are living with AMD; 1.5 million of which are…

Commercial launch strategies require research, insight gathering and decision-making for years in advance of FDA submission. These processes involve complex requirements and often involve timelines and project plans that are mapped out across functional teams and their agency partners. As teams move quickly into “launch mode”, there are many potential shifting priorities requiring contingency plans…